Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?-Reference-Cited by-同舟云学术

Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?

Published:2016-05-03 Issue:3 Volume:28 Page:230-234
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Bozkurt Oktay,Karaca Halit,Hacıbekiroglu Ilhan,Kaplan Muhammed Ali,Duzkopru Yakup,Uysal Mukremin,Berk Veli,Inanc Mevlude,Duran Ayse Ocak,Ozaslan Ersin,Ucar Mahmut,Ozkan Metin

Publisher

Maney Publishing

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference28 articles.

1. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

2. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

3. A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

4. Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

5. Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase Inhibitors and Thyroid Toxicity;Biomedical and Pharmacology Journal;2023-09-30

2. Endocrine-related adverse conditions induced by tyrosine kinase inhibitors;Annales d'Endocrinologie;2023-05

3. Sunitinib-induced small bowel wall edema as a prognostic marker in metastatic renal cell carcinoma;Journal of Cancer Research and Therapeutics;2023

4. Thyroid Dysfunction from Treatments for Solid Organ Cancers;Endocrinology and Metabolism Clinics of North America;2022-06

5. Sunitinib-Induced Hypothyroidism and Survival in Pancreatic Neuroendocrine Tumors;Hormone and Metabolic Research;2021-12